EW Stock Analysis: Buy, Sell, or Hold?
EW - Edwards Lifesciences Corp
$86.07
-0.85 (-0.98%)
▼
5d:
+4.16%
30d:
-6.44%
90d:
+3.08%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Oct 29, 2026
Smart Money Accumulation
None View Scanner →
Strength: 5.5/10
Get Alerted When EW Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: EW shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: EW shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$125.49
Based on 8.3% avg growth
INTRINSIC VALUE TODAY
$77.92
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: EW is currently trading at $86.07, which is considered slightly low relative to its 30-day fair value range of $84.79 to $92.23. The stock's valuation (Forward PE: 25.5) is in line with its historical norms (26.3). Remarkably, the market is currently pricing in an annual earnings decline of 1.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, EW is in a uptrend. Immediate support is located at $81.16, while resistance sits at $89.08.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $100.96 (+17.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, EW is in a uptrend. Immediate support is located at $81.16, while resistance sits at $89.08.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $100.96 (+17.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$84.79 -
$92.23
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($100.96)
Trading Range Analysis
30-Day Trading Range
$84.79 -
$92.23
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$81.16
Resistance Level
$89.08
Current Trend
Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
25.50
Wall Street Target
$100.96
(+17.3%)
Revenue Growth (YoY)
13.6%
Earnings Growth (YoY)
-25.4%
Profit Margin
15.4%
Valuation Discount vs History
-1.0% cheaper
PE vs Historical
25.5 vs 26.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.0%
(market-implied from PE analysis)
1-Year Target
$85.21
(-1%)
2-Year Target
$84.36
(-2%)
3-Year Target
$83.51
(-3%)
3-Yr Target (if PE normalizes)
(PE: 26→26)
$86.15
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 25.5, Growth: 12.6%)
$122.81
(+43%)
Base:
(SPY PE: 20.7, Growth: 12.6%)
$99.85
(+16%)
Bear:
(PE: 17.6, Growth: 12.6%)
$84.87
(-1%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (29x PE), but valuation improves significantly next year (26x PE) as earnings recover.
Forward PE: 28.57 | Forward EPS (Implied): $3.01
Bull Case
$103.93
(+21%)
Analyst growth 15.0%, PE expands to 30.0
Base Case
$86.07
(0%)
Market implied 0.0%, PE stable at 28.6
Bear Case
$65.84
(-24%)
Severe decline -15.0%, PE contracts to 25.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 25.5 to 26.3
Stabilization Target:
$88.79
(+3.2%)
PE Expansion Potential:
+3.2%
Share & Embed Analysis
Last updated: August 02, 2026 10:48 AM ET
Data refreshes hourly during market hours. Next update: 11:48 AM
Data refreshes hourly during market hours. Next update: 11:48 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EW showing a specific setup today?
Insider Activity (6 Months)
1
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Scott B Ullem
SELL
13000 shares
2026-04-09
Daniel J Lippis
SELL
1019 shares
2026-04-06
Donald E Bobo Jr
SELL
22680 shares
2026-04-02
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 51 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 52 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 57 HOLD |
Advanced EW Option Strategies
Professional options setups generated by AI based on today's EW price and gamma walls.
